In previous studies, we showed that the C-terminal domain, F2, but not the N-terminal domain, F1, is responsible for the binding of apolipoprotein [ Fibronectin (Fn) is a large (450 kDa) multidomain protein that interacts with a variety of macromolecules, including components of the cytoskeleton and the extracellular matrix and cell surface receptors particularly of fibroblasts, neurons, macrophages, and bacteria (1). Fn occurs in two main forms: one is insoluble, exhibiting adhesive properties, and is synthesized by fibroblasts, chondrocytes, endothelial cells, epithelial cells, and macrophages; the other is soluble, a heterodimer present in the plasma, and is synthesized by hepatocytes. In both forms there are three internally homologous repeats, called modules (types I, II, and III), that are readily separable by the action of proteolytic enzymes and exhibiting various binding motifs (2). In human soluble Fn, there are 12 type I, 2 type II, and 15 type III modules, each module representing independently folded units containing mostly  sheets and turns ( Fig. 1 ). The first two modules contain four conserved cysteines comprising two disulfide bonds that are critical for module stability and function. In turn, type III modules are devoid of disulfide bonds because the two unpaired cysteines are buried (3, 4). Although Fn is present in early atherosclerotic lesions and in atherosclerotic plaques, its overall role in the atherosclerotic process is unclear (5).Salonen et al. (6)